Vaccination With Live Attenuated Vaccines in Four Children With Chronic Myeloid Leukemia While on Imatinib Treatment

Chronic myeloid leukemia (CML) in childhood and adolescence is a rare malignancy that can successfully be treated with the tyrosine kinase inhibitor (TKI) imatinib. According to the current experience, treatment is necessary for years and, in the majority of cases, a lifelong approach is required to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bettoni da Cunha-Riehm, Claudia, Hildebrand, Verena, Nathrath, Michaela, Metzler, Markus, Suttorp, Meinolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181227/
https://www.ncbi.nlm.nih.gov/pubmed/32362894
http://dx.doi.org/10.3389/fimmu.2020.00628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181227/
https://www.ncbi.nlm.nih.gov/pubmed/32362894
http://dx.doi.org/10.3389/fimmu.2020.00628

Ejemplares similares